Evado
  • Demonstration
  • Evado Clinical
    • Clinical Trials
    • Registries
    • eConsent
    • eCOA
    • Platform
  • About us
    • Evado Background
    • Evado – Virtual Museum
    • Awards & Memberships
    • Patent Trademarks
    • Evado Policies
  • News
  • Careers
  • Resources
  • Contact Us
Close Menu
  • Demonstration
  • Evado Clinical
    • Clinical Trials
    • Registries
    • eConsent
    • eCOA
    • Platform
  • About us
    • Evado Background
    • Evado – Virtual Museum
    • Awards & Memberships
    • Patent Trademarks
    • Evado Policies
  • News
  • Careers
  • Resources
  • Contact Us

Report: Australia 60% cheaper than US for clinical trials

With a tax incentive program making clinical trials up to 60% more cost-effective, Australia is a “gateway” to larger studies throughout Asia, says CRO.

According to the report published by Frost & Sullivan, the clinical trials market is expected to reach $615m by 2019, growing at a CAGR of 12%. Additionally, early phase clinical trials have been growing at nearly twice this rate and growth is expected to continue.